About the Company
We do not have any company description for ANAVEX LIFE SCIENCES CORP. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $AVXL News
Investors Who Lost Money on Anavex Life Sciences Corporation (AVXL) Should Contact Levi & Korsinsky About Pending Class Action - AVXL
NEW YORK, NY / ACCESSWIRE / April 24, 2024 / If you suffered a loss on your Anavex Life Sciences Corporation (NASDAQ:AVXL) investment and want to learn about a potential recovery under the federal ...
Anavex Life Sciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - AVXL
THE LAWSUIT: A class action securities lawsuit was filed against Anavex Life Sciences Corporation that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud ...
Levi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - AVXL
THE LAWSUIT: A class action securities lawsuit was filed against Anavex Life Sciences Corporation that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud ...
Would I Choose Anavex Life Sciences Corporation (NASDAQ: AVXL) Stock At Any Point In Time?
Anavex Life Sciences Corporation (NASDAQ:AVXL) price closed lower on Friday, April 12, dropping -3.48% below its previous ...
Who Got The Work
K&L Gates partner Theodore L. Kornobis has entered an appearance for Anavex Life Sciences Corp., a manufacturer of pharmaceuticals for central nervous system disorders, and its CEO Christopher U.
Evaluating the Impact of -2.28 Increase on Anavex Life Sciences Corporation’s (AVXL) Stock
AVXL stock has gone down by -7.14%, with a monthly decline of -17.34% and a quarterly plunge of -33.07%. The volatility ratio for the week is 4.02%, and the volatility levels for the last 30 days are ...
Levi & Korsinsky Notifies Shareholders of Anavex Life Sciences Corporation (AVXL) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / April 18, 2024 / If you suffered a loss on your Anavex Life Sciences Corporation (NASDAQ:AVXL) investment and want to learn about a potential recovery under the federal ...
Anavex Life Sciences Corp. (AVXL)
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated ...
Anavex Life Sciences Corp
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Anavex Life Sciences Corp.
Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...
Loading the latest forecasts...